Taurine and inflammatory diseases

Amino Acids

Volumn 46, Issue 1, 2014, Pages 7-20

  Marcinkiewicz, Janusz ^a   Kontny, Ewa ^b  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^b INSTITUTE OF RHEUMATOLOGY   (Poland)

Author keywords

Antioxidants; Inflammatory diseases; Myeloperoxidase; Neutrophils; Rheumatoid arthritis; Taurine; Taurine bromamine; Taurine chloramine

Indexed keywords

ANIMALS; ANTI-INFECTIVE AGENTS; APOPTOSIS; ARTHRITIS, RHEUMATOID; BILE ACIDS AND SALTS; CALCIUM; HUMANS; INFLAMMATION; OSMOREGULATION; PEROXIDASE; TAURINE;

EID: 84895869820     PISSN: 09394451     EISSN: 14382199     Source Type: Journal    
DOI: 10.1007/s00726-012-1361-4     Document Type: Review

References (104)

1. Bartok B, Firestein GS (2010) Fibroblast-like synoviocytes: key effector cells in rheumatoid arthritis. Immunol Rev 233:233-255
2. Barua M, Liu Y, Quinn MR (2001) Taurine chloramine inhibits inducible nitric oxide synthase and TNF-alpha gene expression in activated alveolar macrophages: decreased NF-kappaB activation and IkappaB kinase activity. J Immunol 167(4):2275-2281
3. Bouckenooghe T, Remacle C, Reusens B (2006) Is taurine a functional nutrient? Curr Opin Clin Nutr Metab Care 9:728-733
4. Chora̧zy-Massalska M, Kontny E, Kornatka A, Rell-Bakalarska M, Marcinkiewicz J, MaAliński W (2004) The effect of taurine chloramine on pro-inflammatory cytokine production by peripheral blood mononuclear cells isolated from rheumatoid arthritis and osteoarthritis patients. Clin Exp Rheumatol 22(6):692-698
5. Costeron JW, Stewart PS, Greenberg EP (1991) Bacterial biofilms: a common cause of persistent infections. Science 284:1318-1322
6. Detert J, Pischon N, Burmester GR, Buttgereit F (2010) The association between rheumatoid arthritis and periodontal disease. Arthritis Res Ther 12:218
7. Firestein GS (2009) Etiology and pathogenesis of rheumatoid arthritis. In: Firestein GS, Budd RC, Harris T, McInnes IB, Ruddy S, Sergent JS (eds) Kelly's textbook of rheumatology, 8th edn. Saunders Elsevier, Philadelphia, pp 1035-1086
8. Frommer KW, Zimmermann B, Meier FM, Schröder D, Heil M, Schäffler A, Büchler C, Steinmeyer J, Brentano F, Gay S, Müller-Ladner U, Neumann E (2010) Adiponectin-mediated changes in effector cells involved in the pathophysiology of rheumatoid arthritis. Arthritis Rheum 62:2886-2899
9. Gabay C, Lamacchia C, Palmer G (2010) IL-1 pathways in inflammation and human diseases. Nat Rev Rheumatol 6:232-241
10. Gaut JP, Yeh GC, Tran HD, Byun J, Henderson JP, Richter GM, Brennan ML, Lusis AJ, Belaaouaj A, Hotchkiss RS, Heinecke JW (2001) Neutrophils employ the myeloperoxidase system to generate antimicrobial brominating and chlorinating oxidants during sepsis. Proc Natl Acad Sci 98:11961-11966
11. Gierut A, Perlman H, Pope RM (2010) Innate immunity and rheumatoid arthritis. Rheum Dis Clin North Am 36:271-296
12. Gottardi W, Nagl M (2010) N-chlorotaurine, a natural antiseptic with outstanding tolerability. J Antimicrob Chemother 65:399-409
13. Gottardi W, Hagleitner M, Nagl M (2005) N, N-dichlorotaurine: chemical and bactericidal properties. Arch Pharm (Weinheim) 338(10):473-483
14. Green TR, Fellman JH, Eicher AL, Pratt KL (1991) Antioxidant role and subcellular localisation of hypotaurine and taurine in human neutrophils. Biochim Biophys Acta 1073:91-97
15. Gregersen PK, Silver J, Winchester RJ (1987) The shared epitope hypothesis. An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis. Arthritis Rheum 30:178-182
16. Gustafson B (2010) Adipose tissue, inflammation and atherosclerosis. J Atheroscler Thromb 17:332-341
17. Henderson JP, Byun J, Williams MV et al (2001) Production of brominating intermediates by myeloperoxidase. J Biol Chem 11:7867-7875
18. Huxtable RJ (1992) Physiological actions of taurine. Physiol Rev 72:101-163
19. Jang JS, Piao S, Cha YN, Kim Ch (2009) Taurine chloramine activates Nrf2, increases HO-1 expression and protects cells from death caused by hydrogen peroxide. J Clin Biochem Nutr 45:37-43
20. Jeon SH, Lee MY, Rahman MM, Kim SJ et al (2009) The antioxidant, taurine reduced lipopolysaccharide (LPS)-induced generation of ROS, and activation of MAPKs and Bax in cultured pneumocytes. Pulm Pharmacol Ther 22:562-566
21. Jong CJ, Azuma J, Schaffer SW (2011) Role of mitochondrial permeability transition in taurine deficiency-induced apoptosis. Exp Clin Cardiol 16(4):125-128
22. Joo K, Lee Y, Choi D, Han J, Hong S, Kim YM, Jung Y (2009) An anti-inflammatory mechanism of taurine conjugated 5-aminosalicylic acid against experimental colitis: taurine chloramine potentiates inhibitory effect of 5-aminosalicylic acid on IL-1beta-mediated NFkappaβ activation. Eur J Pharmacol 618(1-3):91-97
23. Kim C, Cha YN (2009) Production of reactive oxygen and nitrogen species in phagocytes is regulated by taurine chloramine. Adv Exp Med Biol 643:463-472
24. Kim C, Park E, Quinn MR, Schuller-Levis G (1996) The production of superoxide anion and nitric oxide by cultured murine leukocytes and the accumulation of TNF-α in the conditioned media is inhibited by taurine chloramine. Immunopharmacology 34(2-3):89-95
25. Kim C, Choi HS, Kim JW (2006) Taurine chloramine inhibits the production of nitric oxide and superoxide anion by modulating specific mitogen-activated protein kinases. Adv Exp Med Biol 583:493-498
26. Kim KS, Park EK, Ju SM, Jung HS, Bang JS, Kim C, Lee YA, Hong SJ, Lee SH, Yang HI, Yoo MC (2007) Taurine chloramine differentially inhibits matrix metalloproteinase 1 and 13 synthesis in interleukin-1beta stimulated fibroblast-like synoviocytes. Arthritis Res Ther 9:R80. doi: 10.11.86/ar2279
27. Kim C, Jang JS, Cho MR, Agarawal SR, Cha YN (2010a) Taurine chloramine induces heme oxygenase-1 expression via Nrf2 activation in murine macrophages. Int Immunopharmacol 10(4):440-446
28. Kim KS, Choi HM, da Oh H, Kim C, Jeong JS, Yoo MC, Yang HI (2010b) Effect of taurine chloramine on the production of matrix metalloproteinases (MMPs) in adiponectin- or IL-1beta-stimulated fibroblast-like synoviocytes. J Biomed Sci 17(Suppl 1):S27
29. Klamt F, Shacter E (2005) Taurine chloramine, an oxidant derived from neutrophils, induces apoptosis in human B lymphoma cells through mitochondrial damage. J Biol Chem 280(22):21346-21352
30. Klebanoff SJ (1968) Myeloperoxidase-halide-hydrogen peroxide antibacterial system. J Bacteriol 95:2131-2138
31. Klebanoff SJ (2005) Myeloperoxidase: friend and foe. J Leukoc Biol 77:598-625
32. Klein-Wieringa IR, Kloppenburg M, Bastiaansen-Jenniskens YM, Yusuf E, Kwekkeoopm JC, El-Bannoudi H, Nelissen RG, Zuurmond A, Stojanovic-Susulic V, Van Osch GJ, Toes RE, Ioan-Facsinay A (2011) The infrapetellar fat pad of patients with osteoarthritis has an inflammatory phenotype. Ann Rheum Dis 70:851-857
33. Kontny E, Grabowska A, Kowalczewski J, Kurowska M, Janicka I, Marcinkiewicz J, MaAliński W (1999) Taurine chloramine inhibition of cell proliferation and cytokine production by rheumatoid arthritis fibroblast-like synoviocytes. Arthritis Rheum 42:2552-2560
34. Kontny E, Szczepańska K, Kowalczewski J, Kurowska M, Janicka I, Marcinkiewicz J, MaAliński W (2000) The mechanism of taurine chloramine inhibition of cytokine (IL-6, IL-8) production by rheumatoid arthritis fibroblast-like synoviocytes. Arthritis Rheum 43:2169-2177
35. Kontny E, Wojtecka-Łukasik E, Rell-Bakalarska K, Dziewczopolski W, MaAliński W, MaAlinski S (2002) Impaired generation of taurine chloramine by synovial fluid neutrophils of rheumatoid arthritis patients. Amino Acids 23:415-418
36. Kontny E, MaAliński W, Marcinkiewicz J (2003a) Anti-inflammatory activities of taurine chloramine: implication for immunoregulation and pathogenesis of rheumatoid arthritis. Adv Exp Med Biol 526:329-340
37. Kontny E, Rudnicka W, Kowalczewski J, Marcinkiewicz J, MaAlinski W (2003b) Selective inhibition of cyclooxygenase-2-generated prostaglandin E2 synthesis in rheumatoid arthritis synoviocytes by taurine chloramine. Arthritis Rheum 48:1551-1555
38. Kontny E, Chora̧zy-Massalska M, Rudnicka W, Janicka I, Marcinkiewicz J, MaAliński W (2003c) The effect of taurine and its metabolites on the pathogenic functions of rheumatoid arthritis fibroblast-like synoviocytes. Centr Eur J Immunol 28:167-172
39. Kontny E, Rudnicka W, Chorazy-Massalska M, Marcinkiewicz J, MaAliński W (2006a) Taurine chloramine inhibits proliferation of rheumatoid arthritis synoviocytes by triggering a p53-dependent pathway. Inflamm Res 55:446-455
40. Kontny E, Chora̧zy-Massalska M, Rudnicka W, Marcinkiewicz J, MaAliński W (2006b) Cytotoxicity of taurine metabolites depends on the cell type. Adv Exp Med Biol 583:157-171
41. Kontny E, Chorazy-Massalska M, Rudnicka W, Marcinkiewicz J, MaAliński W (2007) Comparison of taurine chloramine and taurine bromamine effects on rheumatoid arthritis synoviocytes. Amino Acids 32(3):447-452
42. Kontny E, Plebanczyk M, Lisowska B, Olszewska M, Maldyk P, Maslinski W (2012) Comparison of rheumatoid articular adipose and synovial tissue reactivity to proinflammatory stimuli: contribution to adipocytokine network. Ann Rheum Dis 71:262-267
43. KwaAny-Krochin B, Bobek M, Kontny E, Gluszko P, Biedroń R, Chain BM, MaAliński W, Marcinkiewicz J (2002) Effect of taurine chloramine, the product of activated neutrophils, on the development of collagen-induced arthritis in DBA 1/J mice. Amino Acids 23:419-426
44. Learn DB, Fried VA, Thomas EL (1990) Taurine and hypotaurine content of human leukocytes. J Leukoc Biol 48:174-182
45. Low E, Nair S, Shiau T, Belisle B, Debabov D, Celeri C, Zuck M, Najafi R, Georgopapadakou N, Jain R (2009) N,N-dichloroaminosulfonic acids as novel topical antimicrobial agents. Bioorg Med Chem Lett 19(1):196-198
46. Maher SG, Condron CEM, Bouchier-Hayes DJ, Toomey DM (2005) Taurine attenuates CD3/interleukin-2-induced T cell apoptosis in an in vitro model of activation-induced cell death (AICD). Clin Exp Immunol 139:279-286
47. Mainnemare A, Mégarbane B, Soueidan A, Daniel A, Chapple IL (2004) Hypochlorous acid and taurine-N-monochloramine in periodontal diseases. J Dent Res 83(11):823-831
48. Marcinkiewicz J (2009) Taurine bromamine: a new therapeutic option in inflammatory skin diseases. Polish Arch Internal Med 119:673-675
49. Marcinkiewicz J, Kontny E (2012) Taurine, taurine derivatives and immune system. In: A El Idrissi, W L'Amoreaux (eds) Taurine in health and disease, Transworld Research Network Chapter 6, 2011: 000-000 ISBN:978-81-7895-520-9
50. Marcinkiewicz J, Grabowska A, Bereta J, Stelmaszyńska T (1995a) Taurine chloramine a product of activated neutrophils, inhibits in vitro the generation of nitric oxide and other macrophage inflammatory mediators. J Leukoc Biol 58:667-674
51. Marcinkiewicz J, Grabowska A, Bereta J, Stelmaszyńska T (1995b) Taurine chloramine a product of activated neutrophils, inhibits in vitro the release of tumor necrosis factor in activated RAW 264.7 cells. J Leukoc Biol 54:119
52. Marcinkiewicz J, Grabowska A, Bereta J, Bryniarski K, Nowak B (1998) Taurine chloramine down-regulates the generation of murine neutrophil inflammatory mediators. Immunopharmacology 40(1):27-38
53. Marcinkiewicz J, Chain B, Nowak B et al (2000) Antimicrobial and cytotoxic activity of hypochlorous acid: interactions with taurine and nitrite. Inflamm Res 49:280-289
54. Marcinkiewicz J, Mak M, Bobek M, Biedroń R, Białecka A, Koprowski M, Kontny E, MaAliński W (2005) Is there a role of taurine bromamine in inflammation? Interactive effects with nitrite and hydrogen peroxide. Inflamm Res 54(1):42-49
55. Marcinkiewicz J, Biedroń R, Białecka A et al (2006a) Susceptibility of Propionibacterium acnes and Staphylococcus epidermidis to killing by MPO-halide system products. Implication for taurine bromamine as a new candidate for topical therapy in treating acne vulgaris. Arch Immunol Ther Exp 54(1):61-68
56. Marcinkiewicz J, Kurnyta M, Biedroń R, Bobek M, Kontny E, MaAliński W (2006b) Anri-inflammatory effects of taurine derivatives (taurine chloramine, taurine bromamine, and taurolidine) are mediated by different mechanisms. Adv Exp Med Biol 583:481-492
57. Marcinkiewicz J, Głuszko P, Kontny E, KwaAny-Krochin B, Bobek M, Wierzchowski W, Ciszek M, MaAliński W (2007) Is taurolidine a candidate for treatment of rheumatoid arthritis? Clin Exp Rheumatol 25:211-218
58. Marcinkiewicz J, Wojas-Pelc A, Walczewska M, Lipko-Godlewska S, Jachowicz R, Maciejewska A, Białecka A, Kasprowicz A (2008) Topical taurine bromamine, a new candidate in the treatment of moderate inflammatory acne vulgaris. Eur J Dermatol 18:433-439
59. Marcinkiewicz J, Walczewska M, Olszanecki R, Bobek M, Biedroń R, Dulak J, Józkowicz A, Kontny E, MaAlinski W (2009) Taurine haloamines and heme oxygenase-1 cooperate in the regulation of inflammation and attenuation of oxidative stress. Adv Exp Med Biol 643:439-450
60. Martini C, Hammerer-Lercher A, Zuck M, Jekle A, Debabov D, Anderson M, Nagl M (2012) Antimicrobial and anticoagulant activities of N-chlorotaurine, N,N-dichloro-2,2-dimethyltaurine, and N-monochloro-2,2-dimethyltaurine in human blood. Antimicrob Agents Chemother 56(4):1979-1984
61. McCourt M, Wang JH, Sookhai S, Redmond HP (2000) Taurolidine inhibits tumor cell growth in vitro and in vivo. Ann Surg Oncol 7:685-691
62. Muz B, Kontny E, Marcinkiewicz J, MaAliński W (2008) Heme oxygenase-1 participates in the anti-inflammatory activity of taurine chloramine. Amino Acids 35:397-402
63. Nagl M, Teuchner B, Pöttinger E, Ulmer H, Gottardi W (2000a) Tolerance of N-chlorotaurine, a new antimicrobial agent, in infectious conjunctivitis: a phase II pilot study. Ophthalmologica 214(2):111-114
64. Nagl M, Hess MW, Pfaller K, Hengster P, Gottardi W (2000b) Bactericidal activity of micromolar N-chlorotaurine: evidence for its antimicrobial function in the human defense system. Antimicrob Agents Chemother 44:2507-2513
65. Nagl M, Lass-Flörl C, Neher A, Gunkel A, Gottardi W (2001) Enhanced fungicidal activity of N-chlorotaurine in nasal secretion. J Antimicrob Chemother 47(6):871-874
66. Nagl M, Nguyen VA, Gottardi W et al (2003) Tolerability and efficacy of N-chlorotaurine in comparison with chloramine T for treatment of chronic leg ulcers with a purulent coating: a randomized phase II study. Br J Dermatol 149:590-597
67. Neary PM, Hallihan P, Wang JH, Pfirrmann RW, Bouchier-Hayes DJ, Redmond HP (2010) The evolving role of taurolidine in cancer therapy. Ann Surg Oncol 17:1135-1143
68. Neher A, Gstöttner M, Nagl M, Scholtz A, Gunkel AR (2007) N-chlorotaurine - a new safe substance for postoperative ear care. Auris Nasus Larynx 34(1):19-22
69. Neumann E, Fromer KW, Vasile M, Müller-Ladner U (2011) Adipocytokines as diving forces in rheumatoid arthritis and related inflammatory diseases? Arthritis Rheum 63:1159-1169
70. O'Toole GA, Kaplan HB, Kolter R (2000) Biofilm formation as microbial development. Annu Rev Microbiol 54:49-79
71. Oliveira MWS, Minotto JB, de Oliveira MR et al (2010) Scavenging and antioxidant potential of physiological taurine concetrations against different reactive oxygen/nitrogen species. Pharm Raports 62:185-193
72. Olszanecki R, Marcinkiewicz J (2004) Taurine chloramine and taurine bromamine induce heme-oxygenase-1 in resting and LPS-stimulated J774.2 macrophages. Amino Acids 27:29-35
73. Olszanecki R, Kurnyta M, Biedroń R, Chorobik P, Bereta M, Marcinkiewicz J (2008) The role of heme oxygenase-1 in downregulation of PGE2 production by taurine chloramine and taurine bromamine in J774.2 macrophages. Amino Acids 35(2):359-364
74. Park E, Quinn MR, Wright CE, Schuller-Levis G (1993) Taurine chloramine inhibits the synthesis of nitric oxide and the release of tumor necrosis factor in activated RAW 264.7 cells. J Leukoc Biol 54(2):119-124
75. Park E, Schuller-Levis G, Quinn MR (1995) Taurine chloramine inhibits production of nitric oxide and TNF-alpha in activated RAW 264.7 cells by mechanisms that involve transcriptional and translational events. J Immunol 154:4778-4784
76. Park E, Schuller-Levis G, Jia JH, Quinn MR (1997) Preactivation exposure of RAW 264.7 cells to taurine chloramine attenuates subsequent production of nitric oxide and expression of iNOS mRNA. J Leukoc Biol 61(2):161-166
77. Park E, Quinn MR, Schuller-Levis G (2000) Taurine chloramine attenuates the hydrolytic activity of matrix metalloproteinase-9 in LPS-activated murine peritoneal macrophages. Adv Exp Med Biol 483:389-398
78. Quinn MR, Barua M, Liu Y, Serban V (2003) Taurine chloramine inhibits production of inflammatory mediators and iNOS gene expression in alveolar macrophages, a tale of two pathways: part I, NF-kappaB signaling. Adv Exp Med Biol 526:341-348
79. Redmond P et al (1998) Immunonutrition: the role of taurine. Nutrition 14:599-614
80. Rosen H, Klebanoff SJ, Yi Wang et al (2009) Methionine oxidation contributes to bacterial killing by myeloperoxidase system of neutrophils. PNAS 106(44):18686-18691
81. Ryter SW, Otterbein LE, Morse D, Choi AM (2002) Heme oxygenase carbon monoxide signaling pathways: regulation and functional significance. Mol Cell Biochem 234-235(1-2):249-263
82. Schaffer SW, Azuma J, Mozaffari M (2009) Role of antioxidant activity of taurine in diabetes. Can J Physiol Pharmacol 87:91-99
83. Scherer HU, Burmester GR (2011) Adaptive immunity in rheumatic diseases: bystander or pathogenic player? Best Pract Res Clin Rheumatol 25:785-800
84. Schett G, Coates LC, Ash ZR, Finzel S, Conaghan PG (2011) Structural damage in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis: traditional views, novel insights gained from TNF blockade, and concepts for the future. Arthritis Res Ther 13(suppl 1):S4
85. Schneider A, Cack U, Rothe K, Bennek J (2005) Peritoneal taurolidine lavage in children with localized peritonitis due to appendicitis. Pediatr Surg Int 21:445-448
86. Schuller-Levis GB, Park E (2004) Taurine and its chloramine: modulators of immunity. Neurochem Res 29(1):117-126
87. Schuller-Levis G, Metha PD, Rudelli R, Struman J (1990) Immunologic consequences of taurine deficiency in cats. J Leukoc Biol 47:321-331
88. Scott DL (2012) Biologics-based therapy for the treatment of rheumatoid arthritis. Nature 91:30-43
89. Shiau TP, Houchin A, Nair S, Xu P, Low E, Najafi RR, Jain R (2008) Stieglitz rearrangement of N,N-dichloro-beta, beta-disubstituted taurines under mild aqueous conditions. Bioorg Med Chem Lett 19(4):1110-1114
90. Shimizu M, Zhao Z, Ishimoto Y, Satsu H (2009) Dietary taurine attenuates dextran sulfate sodium (DSS)-induced experimental colitis in mice. Adv Exp Med Biol 643:265-271
91. Smith J (1994) Neutrophils, host defence, and inflammation: a double-edged sword. J Leukoc Biol 56:672-686
92. Stofkova A (2009) Leptin and adiponectin: from energy and metabolic dysbalance to inflammation and autoimmunity. Endocr Regul 43:157-168
93. Sturmann JA (1993) Taurine in development. Physiol Rev 73:119-147
94. Thomas EL (1979) Myeloperoxidase, hydrogen peroxide, chloride antimicrobial system: effect of exogenous system on antibacterial action against Escherichia coli. Infect Immun 25:110-114
95. Thomas EL, Bozeman PM, Jefferson MM et al (1995) Oxidation of bromide by the human leukocyte enzymes myeloperoxidase and eosinophil peroxidase. J Biol Chem 270:2906-2913
96. Verdrengh M, Tarkowski A (2005) Inhibition of septic arthritis by local administration of taurine chloramine, a product of activated neutrophils. J Rheumatol 32:1513-1517
97. Wagener FA, Volk HD, Willis D, Abraham NG et al (2003) Different faces of the heme-heme oxygenase system in inflammation. Pharmacol Rev 55:551-571
98. Wang L, Na Zhao, Fang Zhang, Wang Yue, Liang M (2009) Effect of taurine on leukocyte function. Eur J Pharmacol 616:275-280
99. Wang Y, Cha YN, Kim KS, Kim C (2011) Taurine chloramines inhibits osteoclastogenesis and splenic lymphocyte proliferation in mice with collagen-induced arthritis. Eur J Pharmacol 668:325-330
100. Weiss SJ (1988) Tissue destruction by neutrophils. N Engl J Med 320:365-376
101. Weiss SJ, Klein R, Slivka A et al (1982) Chlorination of taurine by human neutrophils: evidence for hypochlorous acid generation. J Clin Invest 70:598-603
102. Willatts S, Radford S, Leitermann M (1995) Effect of antiendotoxic agent, taurolidine, in the treatment of sepsis syndrome: a placebo-controlled, double-blind trial. Crit Care Med 23:1033-1039
103. Wojtecka-Łukasik E, Gujski M, Roguska K, Maslinska D, Maslinski S (2005) Taurine chloramine modifies adjuvant arthritis in rats. Inflamm Res 54(suppl 1):S21-S22
104. Yazdanbakhsh M, Eckmann CM, Roos D (1987) Killing of schistosomula by taurine chloramine and taurine bromamine. Am J Trop Med Hyg 37:106-110